Janux Therapeutics (JANX) Assets (2020 - 2026)
Janux Therapeutics (JANX) posted quarterly Assets of $1.0 billion for Q1 2026, down 2.15% year-over-year from $1.1 billion in Q1 2025, and up 2.66% quarter-over-quarter from $1.0 billion in Q4 2025.
Janux Therapeutics (JANX) Assets (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported Assets for 7 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 2.15% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $1.0 billion (down 2.15% YoY), while the FY2025 annual figure was $1.0 billion, down 5.65% from the prior year.
- Assets rose to $1.0 billion in Q1 2026 per JANX's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Assets topped out at $1.1 billion in Q4 2024 and bottomed at $341.5 million in Q2 2023.
- Historically, Assets has averaged $660.6 million across 5 years, with a median of $689.0 million in 2024.
- Annual changes were most pronounced in 2023 — Assets declined 11.38% — and 2024, when it soared 179.05%.
- Janux Therapeutics' Assets stood at $364.0 million in 2022, then increased by 4.5% to $380.4 million in 2023, then jumped by 179.05% to $1.1 billion in 2024, then decreased by 5.65% to $1.0 billion in 2025, then gained by 2.66% to $1.0 billion in 2026.
- Business Quant data shows JANX's Assets at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Janux Therapeutics | 984.58 Mn | 984.58 Mn | - | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.00 Bn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.06 Bn |
| Sep 30, 2024 | 695.02 Mn |
| Jun 30, 2024 | 691.41 Mn |
| Mar 31, 2024 | 688.98 Mn |
| Dec 31, 2023 | 380.41 Mn |
| Sep 30, 2023 | 386.85 Mn |
| Jun 30, 2023 | 341.50 Mn |
| Mar 31, 2023 | 352.96 Mn |
| Dec 31, 2022 | 364.01 Mn |
| Sep 30, 2022 | 375.76 Mn |
| Jun 30, 2022 | 385.37 Mn |
| Mar 31, 2022 | 368.60 Mn |
| Dec 31, 2021 | 379.82 Mn |
| Sep 30, 2021 | 391.08 Mn |